Hepatitis B: Identification and Management

An update and synthesis of previous hepatitis B guidelines, expanding at-risk groups and medical treatment options

Target Group: Public health officials, organizations, and healthcare professionals involved in the development, delivery, and evaluation of prevention and clinical services

Sponsoring Organization: U.S. Centers for Disease Control and Prevention

Type: Consensus of experts in the fields of prevention, care, and treatment of chronic hepatitis B virus (HBV) infection

Key Points: In the U.S., the number of new HBV infections has declined substantially during the last 2 decades as a result of vaccination programs. Worldwide, however, about 350 million people have chronic HBV infection, and >600,000 people die each year from HBV-related liver disease. Many individuals with HBV infection remain asymptomatic for years; therefore, their contacts are un…

Reviewing Author

Stephen G. Baum, MD

Disclosures

Consultant/Advisory BoardClinical Infectious Diseases

RoyaltiesUpToDate

Editorial BoardsMedical Letter